{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:09Z","timestamp":1791341529182,"version":"4.3.1"},"reference-count":416,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0533203"],"award-info":[{"award-number":["2024ZD0533203"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022LZL001"],"award-info":[{"award-number":["ZR2022LZL001"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071035"],"award-info":[{"award-number":["82071035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371165"],"award-info":[{"award-number":["82371165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218808","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:16:44Z","timestamp":1789453004000},"page":"218808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modulation of ferroptosis bridges radiotherapy and immunotherapy to improve cancer treatment outcomes"],"prefix":"10.1016","volume":"660","author":[{"given":"Hong-Xiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-6483","authenticated-orcid":false,"given":"Miaoqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218808_bib1","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7454","article-title":"Trace elements in pancreatic cancer","volume":"13","author":"Yanjun","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2026.218808_bib5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1158\/1078-0432.CCR-12-0298","article-title":"Molecular pathways: targeted \u03b1-particle radiation therapy","volume":"19","author":"Baidoo","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2011.12.012","article-title":"Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury","volume":"327","author":"Azzam","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib11","first-page":"5","article-title":"Tracing the earliest medical uses of high dose-per-fraction external beam radiation","volume":"1","author":"Kavanagh","year":"2011","journal-title":"J. Radiosurg. SBRT"},{"key":"10.1016\/j.canlet.2026.218808_bib12","first-page":"1301","article-title":"Retrospective study and review of ocular radiation side effects following external-beam Cobalt-60 radiation therapy in 37 dogs and 12 cats","volume":"53","author":"Pinard","year":"2012","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.canlet.2026.218808_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0958-3947(01)00069-3","article-title":"Inverse planning algorithms for external beam radiation therapy","volume":"26","author":"Chui","year":"2001","journal-title":"Med. Dosim."},{"key":"10.1016\/j.canlet.2026.218808_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.radonc.2012.07.001","article-title":"Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial","volume":"104","author":"Gupta","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00066-022-01979-2","volume":"199","author":"Racka","year":"2023","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.canlet.2026.218808_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.addr.2016.11.006","article-title":"Proton therapy - present and future","volume":"109","author":"Mohan","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2026.218808_bib17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.hoc.2019.08.006","article-title":"Proton therapy","volume":"33","author":"LaRiviere","year":"2019","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.canlet.2026.218808_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010969","article-title":"Proton radiation therapy: a systematic review of treatment-related side effects and toxicities","volume":"25","author":"Salem","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ijrobp.2024.05.004","article-title":"Irradiation with carbon ions effectively counteracts hypoxia-related radioresistance in a rat prostate carcinoma","volume":"120","author":"Glowa","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218808_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11060-019-03303-y","article-title":"Carbon ion radiotherapy in the treatment of gliomas: a review","volume":"145","author":"Malouff","year":"2019","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.radonc.2020.05.012","article-title":"Carbon ion radiotherapy in pancreatic cancer: a review of clinical data","volume":"147","author":"Liermann","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1245\/s10434-021-10900-7","article-title":"Carbon ion radiotherapy for locally recurrent rectal cancer","volume":"29","author":"Noticewala","year":"2022","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13014-023-02337-x","article-title":"Efficacy and safety of carbon ion radiotherapy for chordomas: a systematic review and meta-analysis","volume":"18","author":"Dong","year":"2023","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib24","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1038\/s41598-025-87769-z","article-title":"Spatial accuracy of dose delivery significantly impacts the planning target volume margin in linear accelerator-based intracranial stereotactic radiosurgery","volume":"15","author":"Takahashi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218808_bib25","first-page":"61","article-title":"Intracranial stereotactic radiosurgery","volume":"63","author":"Fanous","year":"2019","journal-title":"J. Neurosurg. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107281","article-title":"Stereotactic body radiotherapy for ultra-central lung tumours: a systematic review and meta-analysis and international stereotactic radiosurgery society practice guidelines","volume":"182","author":"Yan","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3171\/2017.9.JNS17545","article-title":"Stereotactic radiosurgery for trigeminal neuralgia: a systematic review","volume":"130","author":"Tuleasca","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.canlet.2026.218808_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","article-title":"Towards clinical translation of FLASH radiotherapy","volume":"19","author":"Vozenin","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216651","article-title":"FLASH radiotherapy: a new milestone in the field of cancer radiotherapy","volume":"587","author":"Tang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2019.06.019","article-title":"Treatment of a first patient with FLASH-Radiotherapy","volume":"139","author":"Bourhis","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib31","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.3390\/ijms21186492","article-title":"FLASH radiotherapy: current knowledge and future insights using proton-beam therapy","volume":"21","author":"Hughes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312506","article-title":"FLASH radiotherapy: benefits, mechanisms, and obstacles to its clinical application","volume":"25","author":"Alhaddad","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib33","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abd668","article-title":"4D radiomics: impact of 4D-CBCT image quality on radiomic analysis","volume":"66","author":"Zhang","year":"2021","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib34","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1002\/mp.17269","article-title":"A review on 4D cone-beam CT (4D-CBCT) in radiation therapy: technical advances and clinical applications","volume":"51","author":"Zhang","year":"2024","journal-title":"Med. Phys."},{"key":"10.1016\/j.canlet.2026.218808_bib35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/mp.16103","article-title":"Deep learning-based motion compensation for four-dimensional cone-beam computed tomography (4D-CBCT) reconstruction","volume":"50","author":"Zhang","year":"2023","journal-title":"Med. Phys."},{"key":"10.1016\/j.canlet.2026.218808_bib36","article-title":"The Pioneer and the father of immunotherapy","volume":"16","author":"Munir","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.canlet.2026.218808_bib37","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3390\/biomedicines12122746","article-title":"Coley's toxin to first approved therapeutic Vaccine-A brief historical account in the progression of immunobiology-based cancer treatment","volume":"12","author":"Devaraja","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2026.218808_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/toxins12040241","article-title":"Talkin\u2019 toxins: from coley's to modern cancer immunotherapy","volume":"12","author":"Carlson","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.canlet.2026.218808_bib39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3389\/fimmu.2017.00829","article-title":"Cancer immunotherapy: historical perspective of a clinical revolution and emerging preclinical animal models","volume":"8","author":"Decker","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5825401","article-title":"Cancer vaccines: toward the next breakthrough in cancer immunotherapy","volume":"2020","author":"Igarashi","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218808_bib42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib43","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2019.02965","article-title":"The intriguing history of cancer immunotherapy","volume":"10","author":"Dobosz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.smim.2016.03.012","article-title":"Dendritic cell development-History, advances, and open questions","volume":"27","author":"Puhr","year":"2015","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nri956","article-title":"Natural killer cells and dendritic cells: rendezvous in abused tissues","volume":"2","author":"Moretta","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib46","first-page":"304","article-title":"Structure and expression of a cloned cDNA for human interleukin-2. 1983","volume":"24","author":"Taniguchi","year":"1992","journal-title":"Biotechnology"},{"key":"10.1016\/j.canlet.2026.218808_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41419-023-06391-x","article-title":"Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy","volume":"15","author":"Babamohamadi","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218808_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-018-0578-4","article-title":"Lessons learned from the blockade of immune checkpoints in cancer immunotherapy","volume":"11","author":"Li","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib50","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1002\/jcp.28358","article-title":"PD-1\/PD-L1 pathway: basic biology and role in cancer immunotherapy","volume":"234","author":"Salmaninejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2026.218808_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41392-022-01022-x","article-title":"Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC","volume":"7","author":"Luo","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib52","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.annonc.2022.06.008","article-title":"Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142","volume":"33","author":"Andr\u00e9","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/d41573-019-00182-w","article-title":"Trends in clinical development for PD-1\/PD-L1 inhibitors","volume":"19","author":"Xin Yu","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.canlet.2026.218808_bib56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumour immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib57","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib59","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","article-title":"Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218808_bib61","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The role of ferroptosis in ionizing radiation-induced cell death and tumour suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218808_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102857","article-title":"Ferroptosis triggered by STAT1- IRF1-ACSL4 pathway was involved in radiation-induced intestinal injury","volume":"66","author":"Kong","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib64","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib66","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, radiotherapy, and combination therapeutic strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib68","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218808_bib69","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","article-title":"Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture","volume":"22","author":"Riegman","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib70","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218808_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108373","article-title":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","volume":"244","author":"Costa","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib72","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218808_bib73","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","article-title":"Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis","volume":"187","author":"Qiu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib74","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-022-01004-z","article-title":"ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumour immunity","volume":"7","author":"Gan","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib75","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling","volume":"572","author":"Wu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","article-title":"Energy-stress-mediated AMPK activation inhibits ferroptosis","volume":"22","author":"Lee","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41392-020-00297-2","article-title":"LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib78","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib79","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","article-title":"GPX4 in cell death, autophagy, and disease","volume":"19","author":"Xie","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218808_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216119","article-title":"Targeting GPX4 in human cancer: implications of ferroptosis induction for tackling cancer resilience","volume":"559","author":"Lee","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib81","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib82","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","article-title":"The diversified role of mitochondria in ferroptosis in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib83","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/s41388-024-02949-x","article-title":"RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis","volume":"43","author":"Xie","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218808_bib84","article-title":"Mitochondrial dysfunction-evoked DHODH acetylation is involved in renal cell ferroptosis during cisplatin-induced acute kidney injury","volume":"11","author":"Liang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218808_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122447","article-title":"Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer","volume":"305","author":"Zhou","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218808_bib86","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1021\/acsnano.3c10133","article-title":"Mitochondria-targeted prodrug nanoassemblies for efficient ferroptosis-based therapy via devastating ferroptosis defense systems","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218808_bib87","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-018-0701-2","article-title":"The metabolite BH4 controls T cell proliferation in autoimmunity and cancer","volume":"563","author":"Cronin","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib88","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jid.2017.05.019","article-title":"The Nrf2\/GCH1\/BH4 axis ameliorates radiation-induced skin injury by modulating the ROS Cascade","volume":"137","author":"Xue","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2026.218808_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib90","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","article-title":"Regulation of ferroptosis by lipid metabolism","volume":"33","author":"Pope","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41417-020-0200-0","article-title":"ESCRT-III-mediated membrane repair in cell death and tumour resistance","volume":"28","author":"Liu","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk0330","article-title":"TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218808_bib93","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218808_bib94","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","article-title":"Copper-dependent autophagic degradation of GPX4 drives ferroptosis","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218808_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-026-01128-z","article-title":"Translating ferroptosis into oncology: challenges, opportunities and future directions","author":"Kang","year":"2026","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib96","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","article-title":"Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke","volume":"177","author":"Alim","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib97","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib98","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3049","article-title":"tumour-specific GPX4 degradation enhances ferroptosis-initiated antitumour immune response in mouse models of pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218808_bib99","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib101","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib102","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.canlet.2026.218808_bib103","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1089\/ars.2019.7803","article-title":"Metabolic responses to reductive stress","volume":"32","author":"Xiao","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.canlet.2026.218808_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.aaw9872","article-title":"Cysteine depletion induces pancreatic tumour ferroptosis in mice","volume":"368","author":"Badgley","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218808_bib105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41418-022-01096-8","article-title":"Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumour initiation","volume":"30","author":"M\u00fcller","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218808_bib106","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1038\/s41467-020-20154-8","article-title":"Ferroptotic damage promotes pancreatic tumourigenesis through a TMEM173\/STING-dependent DNA sensor pathway","volume":"11","author":"Dai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib107","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","article-title":"Ironing out the role of ferroptosis in immunity","volume":"57","author":"Bell","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218808_bib108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib109","doi-asserted-by":"crossref","first-page":"714","DOI":"10.14336\/AD.2023.0717","article-title":"Mitochondria-mediated ferroptosis in diseases therapy: from molecular mechanisms to implications","volume":"15","author":"Feng","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.canlet.2026.218808_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216727","article-title":"Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma","volume":"588","author":"Song","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib111","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib112","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib113","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1038\/s41586-023-06269-0","article-title":"DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition","volume":"619","author":"Mishima","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib114","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12964-022-01025-9","article-title":"The warburg effect modulates DHODH role in ferroptosis: a review","volume":"21","author":"Amos","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218808_bib115","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib116","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006890","article-title":"PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis","volume":"11","author":"Wang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib117","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature11743","article-title":"Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells","volume":"493","author":"Maddocks","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib118","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.tcb.2022.05.005","article-title":"Roles of YAP\/TAZ in ferroptosis","volume":"32","author":"Magesh","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib119","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumour agents using synthetic lethal chemical screening in engineered human tumour cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","article-title":"Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma","volume":"22","author":"An","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib121","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3390\/cancers12092511","article-title":"Radioresistance in glioblastoma and the development of radiosensitizers","volume":"12","author":"Ali","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218808_bib122","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumour resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib123","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib124","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoural lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib125","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1158\/0008-5472.CAN-10-0171","article-title":"Ionizing radiation activates the Nrf2 antioxidant response","volume":"70","author":"McDonald","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib126","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1159\/000458742","article-title":"Up-Regulated ATF4 expression increases cell sensitivity to apoptosis in response to radiation","volume":"41","author":"Zong","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2026.218808_bib127","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41419-020-2618-6","article-title":"TGF-\u03b21-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells","volume":"11","author":"Kim","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib128","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumour suppression, tumour microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib129","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","article-title":"SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45284-z","article-title":"SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma","volume":"13","author":"Shan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218808_bib131","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","article-title":"p53 in ferroptosis regulation: the new weapon for the old guardian","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218808_bib132","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/d41586-017-07291-9","article-title":"The most popular genes in the human genome","volume":"551","author":"Dolgin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib133","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1038\/s41467-021-26213-y","article-title":"Cancer gene mutation frequencies for the U.S. population","volume":"12","author":"Mendiratta","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib134","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk1835","article-title":"Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo","volume":"10","author":"Dibra","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218808_bib136","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1038\/s41388-021-01790-w","article-title":"Ferroptosis as a mechanism to mediate p53 function in tumour radiosensitivity","volume":"40","author":"Lei","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218808_bib137","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41467-021-23902-6","article-title":"iPLA2\u03b2-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib138","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib139","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0003-9861(90)90424-W","article-title":"Purification and characterization of three ribonucleases from human kidney: comparison with urine ribonucleases","volume":"281","author":"Mizuta","year":"1990","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.canlet.2026.218808_bib141","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2012.03.024","article-title":"Targeting a cornerstone of radiation resistance: cancer stem cell","volume":"322","author":"Moncharmont","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib142","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-018-0758-7","article-title":"Role of metabolism in cancer cell radioresistance and radiosensitization methods","volume":"37","author":"Tang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib143","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-020-01180-y","article-title":"Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance","volume":"19","author":"Cui","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib144","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI81130","article-title":"Versatile roles of extracellular vesicles in cancer","volume":"126","author":"Kosaka","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218808_bib145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","article-title":"Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer","volume":"14","author":"Weng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib146","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-019-0748-z","article-title":"Noncoding RNAs in cancer therapy resistance and targeted drug development","volume":"12","author":"Wang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib147","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12951-020-00684-5","article-title":"Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme","volume":"18","author":"Choi","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2026.218808_bib148","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1039\/C9SC02107H","article-title":"Strategies based on metal-based nanoparticles for hypoxic-tumour radiotherapy","volume":"10","author":"Zhang","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib149","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fonc.2018.00090","article-title":"Metabolic reprogramming during multidrug resistance in leukemias","volume":"8","author":"Vidal","year":"2018","journal-title":"Front. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2026.218808_bib150","doi-asserted-by":"crossref","first-page":"i99","DOI":"10.1093\/jrr\/rrw012","article-title":"Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumour radioresistance","volume":"57","author":"Harada","year":"2016","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.canlet.2026.218808_bib151","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.3390\/cancers14235896","article-title":"ACSL3 and ACSL4, distinct roles in ferroptosis and cancers","volume":"14","author":"Yang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218808_bib152","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1038\/s41418-019-0299-4","article-title":"Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia\/reperfusion","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218808_bib153","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12938-024-01288-y","article-title":"Ferroptosis in radiation-induced brain injury: roles and clinical implications","volume":"23","author":"Li","year":"2024","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.canlet.2026.218808_bib154","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12950-019-0216-0","article-title":"Ferroptosis inhibitor alleviates radiation-induced lung fibrosis (RILF) via down-regulation of TGF-\u03b21","volume":"16","author":"Li","year":"2019","journal-title":"J. Inflamm."},{"key":"10.1016\/j.canlet.2026.218808_bib155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbrc.2019.08.165","article-title":"Role of ferroptosis in the process of acute radiation-induced lung injury in mice","volume":"519","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib156","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41420-022-00887-9","article-title":"NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib157","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41420-022-01127-w","article-title":"ACSL4 is essential for radiation-induced intestinal injury by initiating ferroptosis","volume":"8","author":"Ji","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib158","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2022.01.068","article-title":"Ferroptosis plays an important role in promoting ionizing radiation-induced intestinal injuries","volume":"595","author":"Wang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102413","article-title":"NCOA4-mediated ferritinophagy is involved in ionizing radiation-induced ferroptosis of intestinal epithelial cells","volume":"55","author":"Zhou","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1166\/jbn.2021.3008","article-title":"Plasma-derived exosomes boost the healing of irradiated wound by regulating cell proliferation and ferroptosis","volume":"17","author":"Gan","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.canlet.2026.218808_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166287","article-title":"NMN recruits GSH to enhance GPX4-mediated ferroptosis defense in UV irradiation induced skin injury","volume":"1868","author":"Feng","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102143","article-title":"Keratinocyte death by ferroptosis initiates skin inflammation after UVB exposure","volume":"47","author":"Vats","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib163","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib164","article-title":"System Xc -\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumour therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218808_bib165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jgg.2022.06.002","article-title":"Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters","volume":"49","author":"Gao","year":"2022","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.canlet.2026.218808_bib166","article-title":"Activation of the P62-Keap1-Nrf2 pathway protects against ferroptosis in radiation-induced lung injury","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.canlet.2026.218808_bib167","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib168","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1016\/S1470-2045(17)30252-8","article-title":"The future of personalised radiotherapy for head and neck cancer","volume":"18","author":"Caudell","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib169","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-dose radiotherapy reverses tumour immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib170","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijrobp.2020.05.002","article-title":"Effect of low-dose radiation therapy on abscopal responses to hypofractionated radiation therapy and Anti-PD1 in mice and patients with non-small cell lung cancer","volume":"108","author":"Yin","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218808_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110213","article-title":"Low-dose radiotherapy synergizes with iRGD-antiCD3-modified T cells by facilitating T cell infiltration","volume":"194","author":"Zhou","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib172","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41590-024-01896-9","article-title":"T cell dysfunction and therapeutic intervention in cancer","volume":"25","author":"Zebley","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib173","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/cells13110924","article-title":"Apoptosis, a metabolic \u201cHead-to-Head\u201d between tumour and T cells: implications for immunotherapy","volume":"13","author":"Franzese","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218808_bib174","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/cells11030320","article-title":"Immune checkpoint inhibitors in non-small cell lung cancer: progress, challenges, and prospects","volume":"11","author":"Tang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218808_bib176","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218808_bib177","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41419-024-06807-2","article-title":"Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases","volume":"15","author":"Zeng","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib178","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.scib.2021.02.026","article-title":"Ferroptosis: an emerging player in immune cells","volume":"66","author":"Xu","year":"2021","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.canlet.2026.218808_bib179","article-title":"Ferroptosis: a critical moderator in the life cycle of immune cells","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib180","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.celrep.2019.10.070","article-title":"B1 and marginal zone B cells but not follicular B2 cells require Gpx4 to prevent lipid peroxidation and ferroptosis","volume":"29","author":"Muri","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218808_bib181","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64806","article-title":"Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism","volume":"10","author":"Zeitler","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.canlet.2026.218808_bib182","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8+ T cells and fatty acids orchestrate tumour ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib183","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib184","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"10.1016\/j.canlet.2026.218808_bib185","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib186","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib187","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib188","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib189","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2007.10.005","article-title":"Inflammation and cancer: a double-edged sword","volume":"12","author":"Hagemann","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib190","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4726","article-title":"Architects of immunity: how dendritic cells shape CD8+ T cell fate in cancer","volume":"10","author":"Bhandarkar","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib191","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12967-024-06023-8","article-title":"PD-L1 and IFN-\u03b3 modulate non-small cell lung cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-Mediated hyperprogressive disease (HPD)","volume":"23","author":"Angelicola","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218808_bib192","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41420-025-02290-6","article-title":"Deciphering the mechanisms of long non-coding RNAs in ferroptosis: insights into its clinical significance in cancer progression and immunology","volume":"11","author":"Ou","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib193","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41420-020-00355-2","article-title":"Ferroptosis: a new approach for immunotherapy","volume":"6","author":"Zeng","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib194","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41421-024-00682-z","article-title":"DEPDC5 protects CD8+ T cells from ferroptosis by limiting mTORC1-mediated purine catabolism","volume":"10","author":"Li","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113539","article-title":"Ferroptosis in cancer: a new perspective on T cells","volume":"143","author":"Lai","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.canlet.2026.218808_bib196","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/cac2.12519","article-title":"Cellular metabolism: a key player in cancer ferroptosis","volume":"44","author":"Jiang","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib197","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218808_bib198","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10495-022-01795-0","article-title":"Targeting lipid metabolism for ferroptotic cancer therapy","volume":"28","author":"Luo","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2026.218808_bib199","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.immuni.2024.08.003","article-title":"PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoural CD8+ T cell ferroptosis","volume":"57","author":"Ping","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218808_bib200","article-title":"PGAM1 inhibition promotes HCC ferroptosis and synergizes with Anti-PD-1 immunotherapy","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218808_bib201","article-title":"The crosstalk of CD8+ T cells and ferroptosis in cancer","volume":"14","author":"Lin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-023-02925-5","article-title":"Modulating ferroptosis sensitivity: environmental and cellular targets within the tumour microenvironment","volume":"43","author":"Hua","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.868639","article-title":"Ferroptosis-mediated formation of tumour-promoting immune microenvironment","volume":"12","author":"Bi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib204","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/s41467-020-17380-5","article-title":"Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib205","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumour immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib206","doi-asserted-by":"crossref","first-page":"14475","DOI":"10.1021\/acsnano.3c00901","article-title":"Ferroptosis and necroptosis produced autologous tumour cell lysates Co-Delivering with combined immnoadjuvants as personalized in situ nanovaccines for antitumour immunity","volume":"17","author":"Shi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218808_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117298","article-title":"Firing up \u201ccold\u201d tumours: ferroptosis causes immune activation by improving T cell infiltration","volume":"179","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218808_bib208","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139434","article-title":"TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoural ferroptosis","volume":"131","author":"Jiang","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218808_bib209","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumour immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib210","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoural CD8+ T cell effector function and impairs their antitumour ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218808_bib211","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumour immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib212","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s42003-024-07180-8","article-title":"Ferroptosis as a new tool for tumour suppression through lipid peroxidation","volume":"7","author":"Yang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102424","article-title":"Immunogenic tumour cell death promotes dendritic cell migration and inhibits tumour growth via enhanced T cell immunity","volume":"24","author":"Moriya","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2026.218808_bib214","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","article-title":"The multifunctional protein HMGB1: 50 years of discovery","volume":"23","author":"Tang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","article-title":"Immunogenicity of ferroptosis in cancer: a matter of context?","volume":"10","author":"Catanzaro","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150268","article-title":"Immunometabolic characteristics of dendritic cells and its significant modulation by mitochondria-associated signaling in the tumour microenvironment influence cancer progression","volume":"726","author":"Ghosh","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib217","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41467-023-43554-y","article-title":"15-Lipoxygenase promotes resolution of inflammation in lymphedema by controlling treg cell function through IFN-\u03b2","volume":"15","author":"Zamora","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib218","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","article-title":"PD-L1 degradation pathway and immunotherapy for cancer","volume":"11","author":"Gou","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112203","article-title":"Ferroptosis in antitumour therapy: unraveling regulatory mechanisms and immunogenic potential","volume":"134","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.canlet.2026.218808_bib220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-024-02214-5","article-title":"Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib221","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12943-021-01313-x","article-title":"Non-coding RNAs regulation of macrophage polarization in cancer","volume":"20","author":"Mohapatra","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib222","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","article-title":"Metabolic regulation of macrophage polarization in cancer","volume":"5","author":"Mehla","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102463","article-title":"Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing","volume":"56","author":"Hao","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216732","article-title":"Acidosis activates breast cancer ferroptosis through ZFAND5\/SLC3A2 signaling axis and elicits M1 macrophage polarization","volume":"587","author":"Xiong","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41419-022-04775-z","article-title":"Interaction between macrophages and ferroptosis","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib226","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumour-associated macrophages is a potential therapeutic approach to overcome antitumour drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122386","article-title":"Biomimetic inducer enabled dual ferroptosis of tumour and M2-type macrophages for enhanced tumour immunotherapy","volume":"303","author":"Chen","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218808_bib228","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","article-title":"Radiation-induced tumour immune microenvironments and potential targets for combination therapy","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib229","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.7150\/thno.32648","article-title":"Immune targets in the tumour microenvironment treated by radiotherapy","volume":"9","author":"Ozpiskin","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218808_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217133","article-title":"Irradiated tumour cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases","volume":"598","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib231","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumour microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib232","article-title":"Targeting the MCP-GPX4\/HMGB1 axis for effectively triggering immunogenic ferroptosis in pancreatic ductal adenocarcinoma","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218808_bib233","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","article-title":"Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy","volume":"122","author":"Garland","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.canlet.2026.218808_bib234","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123279","article-title":"Recent advances in crosstalk between immune cells and cancer cells with ferroptosis","volume":"360","author":"Yi","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib236","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4049\/jimmunol.2400246","article-title":"Gpx4 regulates invariant NKT cell homeostasis and function by preventing lipid peroxidation and ferroptosis","volume":"213","author":"Sok","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib237","article-title":"Checkpoint TIPE2 limits the helper functions of NK cells in supporting antitumour CD8+ T cells","volume":"10","author":"Bi","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218808_bib238","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1038\/s41467-024-50474-y","article-title":"Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumour immunity","volume":"15","author":"Ye","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib239","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","article-title":"Ferroptosis: emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation","volume":"10","author":"Jin","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib240","doi-asserted-by":"crossref","first-page":"28193","DOI":"10.1021\/acsami.4c04604","article-title":"Targeted ferroptosis-immunotherapy synergy: enhanced antiglioma efficacy with hybrid nanovesicles comprising NK cell-derived exosomes and RSL3-Loaded liposomes","volume":"16","author":"Hao","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2026.218808_bib241","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/imm.13755","article-title":"PD-1: a critical player and target for immune normalization","volume":"172","author":"Liu","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2026.218808_bib242","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","article-title":"Ferroptosis of tumour neutrophils causes immune suppression in cancer","volume":"612","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218808_bib243","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.tips.2023.06.005","article-title":"Ferroptosis of immune cells in the tumour microenvironment","volume":"44","author":"Kim","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib244","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41392-023-01357-z","article-title":"Tumour neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy","volume":"8","author":"Du","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib245","article-title":"Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: a therapeutic strategy for triple-negative breast cancer","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218808_bib246","article-title":"Enhanced photodynamic therapy synergizing with inhibition of tumour neutrophil ferroptosis boosts Anti-PD-1 therapy of gastric cancer","volume":"11","author":"Zhu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218808_bib247","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12915-025-02154-6","article-title":"Harnessing ferroptosis for precision oncology: challenges and prospects","volume":"23","author":"Fern\u00e1ndez-Acosta","year":"2025","journal-title":"BMC Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib248","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anti-tumour chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.canlet.2026.218808_bib249","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/cdd.2008.143","article-title":"Autophagy regulates selective HMGB1 release in tumour cells that are destined to die","volume":"16","author":"Thorburn","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218808_bib250","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.embor.7400205","article-title":"HMGB1 is an endogenous immune adjuvant released by necrotic cells","volume":"5","author":"Rovere-Querini","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2026.218808_bib251","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acs.bioconjchem.4c00488","article-title":"Iron oxide nanoparticles induce macrophage secretion of ATP and HMGB1 to enhance irradiation-led immunogenic cell death","volume":"36","author":"Zhan","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.canlet.2026.218808_bib252","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00018-024-05191-6","article-title":"cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumours","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib253","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-019-0721-x","article-title":"Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy","volume":"12","author":"Li","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib254","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.scib.2023.02.027","article-title":"Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumour immunotherapy","volume":"68","author":"Liang","year":"2023","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.canlet.2026.218808_bib255","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186547","article-title":"Taking the STING out of radiotherapy: STING checkpoints mediate radiation resistance","volume":"134","author":"Brown","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218808_bib256","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113591","article-title":"Manganese improves CD8+ T cell recruitment via cGAS-STING in hepatocellular carcinoma","volume":"143","author":"Fu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.canlet.2026.218808_bib257","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218808_bib258","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib259","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumours","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218808_bib260","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2019.05.003","article-title":"Treg-mediated acquired resistance to immune checkpoint inhibitors","volume":"457","author":"Saleh","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib261","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib262","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41419-021-03745-1","article-title":"Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1-PD-L1+ bregs through PD-L1\/PI3K\/AKT\/NF-\u03baB axis in breast cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib263","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","article-title":"Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib264","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","article-title":"Resistance mechanisms to Anti-PD cancer immunotherapy","volume":"40","author":"Vesely","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cytogfr.2024.08.001","article-title":"Targeting PD-1\/PD-L1 in tumour immunotherapy: mechanisms and interactions with host growth regulatory pathways","volume":"79","author":"Shen","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.canlet.2026.218808_bib266","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007627","article-title":"PER2 binding to HSP90 enhances immune response against oral squamous cell carcinoma by inhibiting IKK\/NF-\u03baB pathway and PD-L1 expression","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101042","article-title":"Inhibition of NF-\u03baB signaling unveils novel strategies to overcome drug resistance in cancers","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218808_bib268","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1158\/1078-0432.CCR-18-2581","article-title":"The reciprocity between radiotherapy and cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib269","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib270","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/s41467-025-57184-z","article-title":"Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial","volume":"16","author":"Yi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib271","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-025-01678-2","article-title":"Anti-TGF-\u03b2\/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumour immunity and mitigate radiation-induced pulmonary fibrosis","volume":"18","author":"Wu","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib272","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1038\/s41598-025-91863-7","article-title":"A retrospective study of radiotherapy combined with immunotherapy for patients with baseline brain metastases from non-small cell lung cancer","volume":"15","author":"Lu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218808_bib273","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12931-025-03157-1","article-title":"Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis","volume":"26","author":"Huang","year":"2025","journal-title":"Respir. Res."},{"key":"10.1016\/j.canlet.2026.218808_bib274","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1021\/jacs.2c13689","article-title":"Multi-enzyme Co-expressed dual-atom nanozymes induce Cascade immunogenic ferroptosis via activating Interferon-\u03b3 and targeting arachidonic acid metabolism","volume":"145","author":"Liu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.canlet.2026.218808_bib275","article-title":"Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases","volume":"10","author":"Huang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218808_bib276","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib277","article-title":"Ferroptosis becomes immunogenic: implications for anti-tumour treatments","volume":"10","author":"Tang","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2026.218808_bib278","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218808_bib279","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrclinonc.2016.30","article-title":"Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?","volume":"13","author":"Bernstein","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41571-018-0119-7","article-title":"Time to abandon single-site irradiation for inducing abscopal effects","volume":"16","author":"Brooks","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib281","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2022.06.017","article-title":"The role of stereotactic ablative body radiotherapy in renal cell carcinoma","volume":"82","author":"Ali","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2026.218808_bib282","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clon.2019.04.006","article-title":"The abscopal effect of stereotactic radiotherapy and immunotherapy: fool's gold or El Dorado?","volume":"31","author":"Xing","year":"2019","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib283","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","article-title":"Recent progress in ferroptosis: inducers and inhibitors","volume":"8","author":"Du","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218808_bib284","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.canlet.2026.218808_bib285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib286","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225931","article-title":"Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo","volume":"14","author":"Shibata","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218808_bib287","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218808_bib288","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nchembio753","article-title":"Purmorphamine activates the hedgehog pathway by targeting smoothened","volume":"2","author":"Sinha","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib289","doi-asserted-by":"crossref","first-page":"32280","DOI":"10.18632\/oncotarget.25794","article-title":"xCT inhibition sensitizes tumours to \u03b3-radiation via glutathione reduction","volume":"9","author":"Cobler","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218808_bib290","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/OTT.S254995","article-title":"The role of erastin in ferroptosis and its prospects in cancer therapy","volume":"13","author":"Zhao","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib291","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106244","article-title":"Epigenetic regulation of the DNMT1\/MT1G\/KLF4\/CA9 axis synergises the anti-tumour effects of sorafenib in hepatocellular carcinoma","volume":"180","author":"Wei","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218808_bib292","article-title":"Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or chemoradiotherapy in resectable esophageal cancer: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib293","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/CMAR.S391529","article-title":"Safety and efficacy of concurrent or sequential radiotherapy plus (PD-1) inhibitors in oligometastatic esophageal cancer","volume":"15","author":"Duan","year":"2023","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.canlet.2026.218808_bib294","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1001\/jamaoncol.2021.5009","article-title":"Immunotherapy adverse effects","volume":"7","author":"Brown","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib295","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/j.cllc.2019.02.018","article-title":"Relationship between prior radiotherapy and checkpoint-inhibitor pneumonitis in patients with advanced non-small-cell lung cancer","volume":"20","author":"Voong","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib296","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103438","article-title":"RSL3 sensitizes glioma cells to ionizing radiation by suppressing TGM2-dependent DNA damage repair and epithelial-mesenchymal transition","volume":"78","author":"Wang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib297","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaoncol.2024.5403","article-title":"Stereotactic body radiotherapy vs sorafenib alone in hepatocellular carcinoma: the NRG Oncology\/RTOG 1112 phase 3 randomized clinical trial","volume":"11","author":"Dawson","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib298","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2015.07.031","article-title":"Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-Dependent mechanism","volume":"368","author":"Ma","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib299","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00280-008-0894-4","article-title":"The xc- cystine\/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine","volume":"64","author":"Guan","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218808_bib300","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2018.06.018","article-title":"CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer","volume":"432","author":"Kim","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib301","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/0008-5472.CAN-20-1641","article-title":"MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system Xc-\/Glutathione axis","volume":"81","author":"Floros","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib302","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ddr.21557","article-title":"Novel analogs of sulfasalazine as system xc- antiporter inhibitors: insights from the molecular modeling studies","volume":"80","author":"Patel","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.canlet.2026.218808_bib303","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122411","article-title":"Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer","volume":"339","author":"Takatani-Nakase","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib304","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3389\/fonc.2019.01398","article-title":"Erastin reverses ABCB1-Mediated docetaxel resistance in ovarian cancer","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib305","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","article-title":"System Xc-: a key regulatory target of ferroptosis in cancer","volume":"39","author":"Liu","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.canlet.2026.218808_bib306","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41388-017-0082-2","article-title":"MiRNA-646-mediated reciprocal repression between HIF-1\u03b1 and MIIP contributes to tumourigenesis of pancreatic cancer","volume":"37","author":"Niu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218808_bib307","first-page":"323","article-title":"Erastin\/Sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2\/xCT pathway","volume":"19","author":"Li","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib308","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41419-023-05558-w","article-title":"SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase","volume":"14","author":"Xu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib309","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13402-024-01017-6","article-title":"Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1","volume":"48","author":"Yang","year":"2025","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib310","first-page":"59","article-title":"A quality-of-life study in patients with anaphylaxis to Hymenoptera venom in Iran","volume":"23","author":"Bemaniyan","year":"2024","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.canlet.2026.218808_bib311","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","article-title":"IFN\u03b3-mediated repression of system xc- drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells","volume":"110","author":"Kong","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib312","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/nano14131088","article-title":"Quantum dots as a potential multifunctional material for the enhancement of clinical diagnosis strategies and cancer treatments","volume":"14","author":"Guo","year":"2024","journal-title":"Nanomaterials"},{"key":"10.1016\/j.canlet.2026.218808_bib313","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj8833","article-title":"A nonferrous ferroptosis-like strategy for antioxidant inhibition-synergized nanocatalytic tumour therapeutics","volume":"7","author":"Wu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218808_bib314","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.freeradbiomed.2017.09.002","article-title":"Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma","volume":"112","author":"Ou","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2026.218808_bib315","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.7150\/thno.55482","article-title":"Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218808_bib316","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-020-00253-0","article-title":"Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib317","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.3390\/molecules27165207","article-title":"Anti-cancer effects of auranofin in human lung cancer cells by increasing intracellular ROS levels and depleting GSH levels","volume":"27","author":"Cui","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2026.218808_bib318","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.45","article-title":"The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma","volume":"4","author":"Tagde","year":"2014","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.canlet.2026.218808_bib319","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12951-023-01998-w","article-title":"Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination","volume":"21","author":"Rao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2026.218808_bib320","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.chembiol.2022.11.003","article-title":"Small-molecule allosteric inhibitors of GPX4","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib321","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","article-title":"RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer","volume":"9","author":"Sui","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218808_bib322","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116387","article-title":"ML162 derivatives incorporating a naphthoquinone unit as ferroptosis\/apoptosis inducers: design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation","volume":"270","author":"Ma","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218808_bib323","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103887","article-title":"Ferroptosis induction via targeting metabolic alterations in head and neck cancer","volume":"181","author":"Lee","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2026.218808_bib324","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115343","article-title":"Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells","volume":"254","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218808_bib325","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: a novel anti-tumour action for cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2026.218808_bib326","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41419-021-04306-2","article-title":"Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib327","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","article-title":"Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs","volume":"483","author":"Su","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib328","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12951-021-01058-1","article-title":"Simvastatin induced ferroptosis for triple-negative breast cancer therapy","volume":"19","author":"Yao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2026.218808_bib329","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s42003-024-07067-8","article-title":"Mevalonate pathway inhibition reduces bladder cancer metastasis by modulating RhoB protein stability and integrin \u03b21 localization","volume":"7","author":"Wang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib330","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.gendis.2020.09.005","article-title":"Ferroptosis: an emerging therapeutic opportunity for cancer","volume":"9","author":"Wang","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib331","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1158\/1078-0432.CCR-20-1967","article-title":"Statins as anti-tumour agents in the era of precision medicine","volume":"26","author":"Longo","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib332","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12885-022-10465-y","article-title":"Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition","volume":"23","author":"Amos","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib333","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.7150\/jca.58500","article-title":"FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib334","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12964-023-01296-w","article-title":"Targeting ferroptosis in melanoma: cancer therapeutics","volume":"21","author":"Khorsandi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218808_bib335","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104440","article-title":"Targeting ferroptosis suppressor protein 1 in cancer therapy: implications and perspectives, with emphasis on head and neck cancer","volume":"202","author":"Roh","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2026.218808_bib336","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.chembiol.2023.04.007","article-title":"Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis","volume":"30","author":"Hendricks","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib337","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2023.03.001","article-title":"Ferroptosis suppressor protein 1 inhibition promotes tumour ferroptosis and anti-tumour immune responses in liver cancer","volume":"16","author":"Cheu","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218808_bib338","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41419-023-05787-z","article-title":"Molecular characterization of AIFM2\/FSP1 inhibition by iFSP1-like molecules","volume":"14","author":"Xavier da Silva","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib339","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1021\/acsnano.2c01619","article-title":"Carbon quantum dots-based nanozyme from coffee induces cancer cell ferroptosis to activate antitumour immunity","volume":"16","author":"Yao","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218808_bib340","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12951-024-02457-w","article-title":"A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumour ferroptosis therapy","volume":"22","author":"Yang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2026.218808_bib341","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1021\/acs.nanolett.8b03905","article-title":"Amplification of tumour oxidative stresses with liposomal fenton catalyst and glutathione inhibitor for enhanced cancer chemotherapy and radiotherapy","volume":"19","author":"Dong","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib342","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1021\/acsbiomaterials.9b00461","article-title":"Fe2+\/Fe3+ ions chelated with ultrasmall polydopamine nanoparticles induce ferroptosis for cancer therapy","volume":"5","author":"Chen","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.canlet.2026.218808_bib343","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem Biol"},{"key":"10.1016\/j.canlet.2026.218808_bib344","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.3390\/molecules26185460","article-title":"Molecular determinant of DIDS analogs targeting RAD51 activity","volume":"26","author":"Velic","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2026.218808_bib345","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00432-024-06029-1","article-title":"Zinc oxide nanoparticles mitigate the malignant progression of ovarian cancer by mediating autophagy-dependent ferroptosis","volume":"150","author":"Gu","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib346","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s00204-024-03792-5","article-title":"Cell-cell contacts prevent t-BuOOH-triggered ferroptosis and cellular damage in vitro by regulation of intracellular calcium","volume":"98","author":"Faust","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.canlet.2026.218808_bib347","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41419-020-2384-5","article-title":"\u201cIron free\u201d zinc oxide nanoparticles with ion-leaking properties disrupt intracellular ROS and iron homeostasis to induce ferroptosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib348","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41401-020-0439-x","article-title":"ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma","volume":"42","author":"Feng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.canlet.2026.218808_bib349","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/cac2.12319","article-title":"PKC\u03b2II-ACSL4 pathway mediating ferroptosis execution and anti-tumour immunity","volume":"42","author":"Lei","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib350","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/pharmaceutics14020395","article-title":"Artemisinin-type drugs in tumour cell death: mechanisms, combination treatment with biologics and nanoparticle delivery","volume":"14","author":"Zhou","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2026.218808_bib351","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3892\/or.2021.8191","article-title":"Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response-induced upregulation of CHAC1 expression","volume":"46","author":"Wang","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2026.218808_bib352","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","article-title":"The Gold complex auranofin: new perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib353","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101949","article-title":"Auranofin reveals therapeutic anti-tumour potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer","volume":"42","author":"Freire Boullosa","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib354","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182921","article-title":"Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells","volume":"12","author":"Ma","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218808_bib355","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.208","article-title":"Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells","volume":"7","author":"Ma","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib356","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","article-title":"FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation","volume":"14","author":"Gaschler","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib357","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acschembio.5b00900","article-title":"Five-membered ring peroxide selectively initiates ferroptosis in cancer cells","volume":"11","author":"Abrams","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib358","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.133","article-title":"Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells","volume":"8","author":"Basit","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib359","doi-asserted-by":"crossref","first-page":"31846","DOI":"10.1021\/acsnano.4c08083","article-title":"Nutritional glutamine-modified iron-delivery system with enhanced endocytosis for ferroptosis therapy of pancreatic tumours","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218808_bib360","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.tips.2023.08.012","article-title":"Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitors","volume":"44","author":"Scarpellini","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib361","article-title":"New deferric amine compounds efficiently chelate excess iron to treat iron overload disorders and to prevent ferroptosis","volume":"9","author":"Feng","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218808_bib362","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib363","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00280-021-04343-w","article-title":"Zileuton inhibits arachidonate-5-lipoxygenase to exert antitumour effects in preclinical cervical cancer models","volume":"88","author":"Li","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218808_bib364","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","article-title":"Ferroptosis: mechanisms and implications for cancer development and therapy response","volume":"33","author":"Dos Santos","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib365","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2026.218808_bib366","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biology, and Disease, Cell"},{"key":"10.1016\/j.canlet.2026.218808_bib367","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/s41418-019-0304-y","article-title":"Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA","volume":"26","author":"Wang","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218808_bib368","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib369","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","article-title":"A guideline on the molecular ecosystem regulating ferroptosis","volume":"26","author":"Dai","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218808_bib370","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-025-02337-3","article-title":"Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance","volume":"24","author":"Bhowmick","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib371","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2018.06.012","article-title":"Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1\/2 mediated mitochondrial dysfunction","volume":"432","author":"Lan","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218808_bib372","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/antiox13040424","article-title":"Deferasirox causes leukaemia cell death through Nrf2-Induced ferroptosis","volume":"13","author":"Hsu","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.canlet.2026.218808_bib373","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3469840","article-title":"Transcriptome investigation and in vitro verification of curcumin-induced HO-1 as a feature of ferroptosis in breast cancer cells","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.canlet.2026.218808_bib374","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3349\/ymj.2021.62.9.843","article-title":"Temozolomide drives ferroptosis via a DMT1-Dependent pathway in glioblastoma cells","volume":"62","author":"Song","year":"2021","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.canlet.2026.218808_bib375","first-page":"5508","article-title":"Targeting ferroptosis for cancer therapy: iron metabolism and anti-tumour immunity","volume":"11","author":"Luo","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib376","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12951-023-01951-x","article-title":"Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis","volume":"21","author":"Wei","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2026.218808_bib377","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00262-012-1324-3","article-title":"Rosiglitazone and gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer","volume":"62","author":"Bunt","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2026.218808_bib378","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1038\/s41467-024-50678-2","article-title":"Rosiglitazone and trametinib exhibit potent anti-tumour activity in a mouse model of muscle invasive bladder cancer","volume":"15","author":"Plumber","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib379","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.7150\/ijbs.72251","article-title":"Emerging mechanisms and targeted therapy of ferroptosis in neurological diseases and neuro-Oncology","volume":"18","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218808_bib380","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","article-title":"Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1","volume":"11","author":"Kong","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2026.218808_bib381","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41401-024-01258-z","article-title":"Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2\/STAT3\/GPX4 axis","volume":"45","author":"Lai","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.canlet.2026.218808_bib382","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41419-021-04296-1","article-title":"LncRNA RP11-89 facilitates tumourigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib383","article-title":"Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis","volume":"14","author":"Zheng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218808_bib384","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201369","article-title":"Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase","volume":"13","author":"Hinman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218808_bib385","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41419-021-04008-9","article-title":"GPX4 and vitamin E cooperatively protect hematopoietic stem and progenitor cells from lipid peroxidation and ferroptosis","volume":"12","author":"Hu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218808_bib386","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1038\/s41467-022-34096-w","article-title":"A noncanonical function of EIF4E limits ALDH1B1 activity and increases susceptibility to ferroptosis","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218808_bib387","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41523-021-00313-w","article-title":"Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer","volume":"7","author":"Liu","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.canlet.2026.218808_bib388","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1080\/15548627.2021.1872241","article-title":"Tumour heterogeneity in autophagy-dependent ferroptosis","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218808_bib389","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1038\/s41598-025-89127-5","article-title":"Bafilomycin A1 induces colon cancer cell death through impairment of the endolysosome system dependent on iron","volume":"15","author":"Min","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218808_bib390","article-title":"ANO1-Mediated inhibition of cancer ferroptosis confers immunotherapeutic resistance through recruiting cancer-associated fibroblasts","volume":"10","author":"Jiang","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218808_bib391","article-title":"2D catalytic nanozyme enables Cascade enzyodynamic effect-boosted and Ca2+ overload-induced synergistic ferroptosis\/Apoptosis in tumour","volume":"36","author":"Wang","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.canlet.2026.218808_bib392","first-page":"230","article-title":"Genetic determinants of thrombosis","volume":"134","author":"Lowenstein","year":"2024","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.canlet.2026.218808_bib393","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122795","article-title":"Responsive and traceless assembly of iron nanoparticles and 131I labeled radiopharmaceuticals for ferroptosis enhanced radio-immunotherapy","volume":"313","author":"Shen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218808_bib394","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202309537","article-title":"Cu2WS4-PEG nanozyme as multifunctional sensitizers for enhancing immuno-radiotherapy by inducing ferroptosis","volume":"20","author":"Fu","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.canlet.2026.218808_bib395","article-title":"Camouflaged nanozymes with oxidation-promoting activities triggering ferroptosis for radio-immunotherapy","volume":"12","author":"Qiao","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218808_bib396","article-title":"A molybdenum disulfide nanozyme with charge-enhanced activity for ultrasound-mediated cascade-catalytic tumour ferroptosis","volume":"62","author":"Wang","year":"2023","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2026.218808_bib397","article-title":"Biomineralized RuO2 nanozyme with multi-enzyme activity for ultrasound-triggered peroxynitrite-boosted ferroptosis","volume":"19","author":"Liu","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.canlet.2026.218808_bib398","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218808_bib399","article-title":"Cell death in photodynamic therapy: from oxidative stress to anti-tumour immunity","volume":"1872","author":"Donohoe","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2026.218808_bib400","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib401","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1158\/0008-5472.CAN-21-4122","article-title":"Forging forward in photodynamic therapy","volume":"82","author":"Cramer","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218808_bib402","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1002\/anie.201903968","article-title":"Organic photodynamic nanoinhibitor for synergistic cancer therapy","volume":"58","author":"Jiang","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2026.218808_bib403","doi-asserted-by":"crossref","first-page":"12261","DOI":"10.1021\/acsnano.4c00844","article-title":"Light-triggered nanozymes remodel the tumour hypoxic and immunosuppressive microenvironment for ferroptosis-enhanced antitumour immunity","volume":"18","author":"Fan","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2026.218808_bib404","article-title":"Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy","volume":"16","author":"Jiang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.canlet.2026.218808_bib405","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402474","article-title":"Glutathione-depleted photodynamic nanoadjuvant for triggering nonferrous ferroptosis to amplify radiotherapy of breast cancer","volume":"13","author":"Shi","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.canlet.2026.218808_bib406","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: the dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib407","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218808_bib408","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218808_bib409","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218808_bib410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107331","article-title":"Ferroptosis inducers: a new frontier in cancer therapy","volume":"146","author":"Ma","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.canlet.2026.218808_bib411","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170071","article-title":"CD8+ T cells sustain antitumour response by mediating crosstalk between adenosine A2A receptor and glutathione\/GPX4","volume":"134","author":"Chen","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218808_bib412","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumours","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218808_bib413","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add8539","article-title":"Ferroptosis MRI for early detection of anti-tumour drug-induced acute cardiac\/kidney injuries","volume":"9","author":"Zeng","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218808_bib414","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/s41557-025-01966-x","article-title":"Live-cell imaging with fluorogenic radical-trapping antioxidant probes reveals the onset and progression of ferroptosis","volume":"17","author":"Xu","year":"2025","journal-title":"Nat. Chem."},{"key":"10.1016\/j.canlet.2026.218808_bib415","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220825","article-title":"Ferroptosis, a key to unravel the enigma of the FLASH effect?","volume":"95","author":"Vilaplana-Lopera","year":"2022","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218808_bib416","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","article-title":"Decoding ferroptosis for cancer therapy","volume":"25","author":"Wahida","year":"2025","journal-title":"Nat. Rev. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:21:17Z","timestamp":1791339677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":416,"alternative-id":["S0304383526005720"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218808","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of ferroptosis bridges radiotherapy and immunotherapy to improve cancer treatment outcomes","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218808"}}